Thermobalancing therapy is an advanced medical technology known for its effective and safe approach to treating men wi ...

The "Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market" report has been added to Research and Markets' offering. This analysis includes a discussion of products, competitors, ...

ProUroCare Medical, Inc., of Minneapolis, Minn., has filed a de novo application with the FDA seeking marketing clearance for its prostate mechanical imaging (PMI) device (ProUroScan). This will allow ...

Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) issued draft guidance Tuesday to support clinical testing of high-intensity ultrasound systems for ...

Prostatitis and BPH (benign prostatic hyperplasia) are distinct conditions affecting the prostate gland. Although both conditions involve the prostate, they have different causes, symptoms, treatments ...

The prostate is a small gland that forms part of the male reproductive system. Prostate cancer and prostatitis are two conditions that can affect the prostate and may present with similar symptoms.